Reveal LINQ vs Vivid E80

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Medtronic
VS
by GE HealthCare

AI Verdict

Tool A (Reveal LINQ) is an implantable cardiac monitor focused on long-term, continuous ECG recording and AI-powered detection of arrhythmias. Tool B (Vivid E80) is an AI-enhanced ultrasound system designed for real-time cardiovascular imaging and diagnostic analysis of cardiac structures and function. While both leverage AI in cardiology, they serve distinct diagnostic purposes: one for prolonged arrhythmia surveillance, the other for detailed anatomical and functional assessment.

Choose Reveal LINQ if…

Choose Reveal LINQ if you need long-term, continuous cardiac rhythm monitoring for up to three years to diagnose infrequent or elusive arrhythmias, such as those associated with cryptogenic stroke or unexplained syncope. This tool is ideal for patients requiring discreet, prolonged ECG assessment without active patient interaction, providing AI-powered detection of critical cardiac events.

View Reveal LINQ →

Choose Vivid E80 if…

Choose Vivid E80 if you require advanced, real-time cardiovascular ultrasound imaging with integrated AI for enhanced diagnostic precision and workflow efficiency in a clinical setting. This system is best suited for cardiologists and radiologists needing to quickly and accurately assess cardiac structure and function, utilizing features like AI Auto Measure 2D and Easy AutoEF for immediate diagnostic insights.

View Vivid E80 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Reveal LINQ Vivid E80
Pricing Unknown Quote-based
Deployment The Reveal LINQ ICM is an implantable device placed just beneath the skin in the upper left side of the chest through a small incision. The system includes a MyCareLink™ Monitor, a bedside unit that collects data from the ICM and sends it to the doctor. The Reveal LINQ Mobile Manager app, used by healthcare professionals, is downloaded to an iPad or Android tablet and paired via Bluetooth to a Medtronic patient connector, which communicates with the ICMs. On-premise (medical device)
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Reveal LINQ

Reveal LINQ offers superior patient usability as an implantable device providing continuous, passive monitoring for up to three years with a minimally invasive insertion procedure. For clinicians, its mobile app for device management and wireless data transmission to the CareLink network provides a flexible and modern workflow. In contrast, the Vivid E80, while featuring AI to enhance workflow, remains an active, hands-on ultrasound system requiring trained operators.

Clinical Value

Reveal LINQ

Reveal LINQ provides unique clinical value by offering long-term, continuous ECG monitoring for up to three years, which is critical for detecting infrequent and elusive cardiac arrhythmias associated with conditions like cryptogenic stroke and unexplained syncope. Its AccuRhythm AI algorithms also reduce false alerts, improving diagnostic accuracy. While Vivid E80 enhances real-time diagnostic imaging with AI, Reveal LINQ addresses a fundamental diagnostic gap for intermittent events that traditional methods often miss.

Pricing & Value

Tie

Both tools have non-transparent, quote-based pricing, which is standard for high-value medical devices from major manufacturers. Without specific pricing details for either product, it is impossible to conduct a direct comparison of their cost-effectiveness or overall value proposition. Both are likely covered by insurance and offer significant clinical benefits that justify their investment.

Enterprise Readiness

Vivid E80

Both Medtronic and GE HealthCare are established enterprise vendors with FDA clearance and HIPAA compliance. However, Tool B (Vivid E80) explicitly states 'has_baa: yes' in its structured facts, indicating a clear formal business associate agreement. Tool A (Reveal LINQ) states its BAA is 'implied by HIPAA compliance...but not explicitly stated as a separate business associate agreement (BAA) for the device itself,' giving Tool B a slight edge in explicit contractual readiness for enterprise deployments.

Innovation

Reveal LINQ

Reveal LINQ demonstrates a higher degree of innovation with its claim as the 'world's smallest insertable cardiac monitor' and its ability to provide continuous ECG monitoring for up to three years. This miniaturization, combined with AI algorithms for reduced false alerts, represents a significant advancement in long-term, passive cardiac diagnostics. While Vivid E80 integrates advanced AI features into ultrasound imaging, Reveal LINQ's innovation fundamentally changes the form factor and duration of cardiac monitoring.

Support & Docs

Tie

Both Medtronic and GE HealthCare are leading medical device manufacturers known for comprehensive support and documentation. Web searches confirm that both companies provide extensive resources, including user manuals, technical support, and patient education materials. Without specific comparative metrics on the breadth, accessibility, or responsiveness of their support services, it is not possible to definitively pick a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Reveal LINQ Vivid E80
Name Reveal LINQ Vivid E80
Company Medtronic GE HealthCare
Description Medtronic Reveal LINQ is a tiny, implantable cardiac monitor that continuously records ECG for up to three years, utilizing AccuRhythm™ AI algorithms to accurately detect and diagnose cardiac arrhythmias, including atrial fibrillation, cryptogenic stroke, and unexplained syncope. GE HealthCare's Vivid E80, E90, and E95 are advanced AI-powered ultrasound systems for cardiovascular imaging, not physician directory tools. They enhance diagnostic precision and workflow efficiency through integrated AI features.
Categories Cardiology AI, Wearables & Remote Monitoring (RPM) Cardiology AI, Radiology & Imaging AI
Specialties Cardiology, Neurology Cardiology, Radiology
Key Features World's smallest insertable cardiac monitor (1.2 mL), Continuous ECG monitoring for up to three years, AccuRhythm™ AI algorithms for reduced false alerts (AF and pause), Automatic and patient-activated event recording, MRI Conditional (1.5T and 3T) with no post-insertion waiting, Minimally invasive, simplified insertion procedure, Wireless data transmission to CareLink™ network via MyCareLink™ Patient Monitor, Reveal LINQ™ Mobile Manager app for clinician device management AI Auto Measure 2D (for left ventricle dimensions), Easy AutoEF (AI-based ejection fraction measurement), Easy AFI LV (AI-based global and segmental strain measurements), AI Cardiac Auto Doppler, AI FlexiViews LAA (Left Atrial Appendage localization), Auto Tissue (real-time image processing for automatic gain optimization), Spectrum Recognition (semi-automatic Doppler spectrum measurement), DICOM® connectivity for image processing and reporting

Videos

Demos, reviews, and walkthroughs featuring Reveal LINQ and Vivid E80.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Reveal LINQ is an implantable cardiac monitor designed for continuous ECG recording to detect cardiac arrhythmias such as atrial fibrillation, cryptogenic stroke, and unexplained syncope for up to three years. In contrast, the Vivid E80 is an advanced AI-powered ultrasound system primarily used for real-time cardiovascular imaging to enhance diagnostic precision and workflow efficiency.
The Reveal LINQ utilizes AccuRhythmu2122 AI algorithms to accurately detect and diagnose cardiac arrhythmias and reduce false alerts for AF and pause events. The Vivid E80 integrates AI features for automated measurements of left ventricle dimensions (AI Auto Measure 2D), ejection fraction (Easy AutoEF), global and segmental strain (Easy AFI LV), AI Cardiac Auto Doppler, and AI FlexiViews LAA for Left Atrial Appendage localization, enhancing imaging and workflow efficiency.
The Reveal LINQ provides continuous ECG monitoring for an extended period of up to three years, capturing transient or infrequent cardiac events. The Vivid E80 provides real-time diagnostic cardiovascular images and measurements during an ultrasound examination, offering immediate insights into cardiac structure and function.
GE HealthCare explicitly states that the Vivid E80 has a Business Associate Agreement (BAA). For the Medtronic Reveal LINQ, a BAA is implied by HIPAA compliance for medical devices handling protected health information, but it is not explicitly stated as a separate BAA for the device itself, though Medtronic emphasizes dedicated protection of patient health data.
The Reveal LINQ is primarily targeted at Cardiology and Neurology specialties due to its focus on detecting cardiac arrhythmias, cryptogenic stroke, and unexplained syncope. The Vivid E80 is designed for Cardiology and Radiology specialties, focusing on advanced cardiovascular imaging.
AI Tool Finder
AI-powered search. Results may not be comprehensive.